Capital Flow Monitor · Sponsors · CIK 1478304
Noveome Biotherapeutics, Inc.
620 ALPHA DRIVE, PITTSBURGH, PA, 15238 · 412-799-6157
Biotechnology · Corporation· inc. DELAWARE true
Fit score
—
Offering
$15.0M
Sold
$6.8M
% sold
45.0%
Investors
6
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-08-27 | D ·current | 506(b) | $15.0M | $6.8M | 45.0% | 6 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Patrick Welch — Executive Officer / Director, Pittsburgh, PA
-
Robert Langer — Director, Pittsburgh, PA
3 other raises
- EpiBone, Inc. $4.3M of $4.3M · 99.7%
- VitaKey Inc. $0 of $43.5M · 0.0%
- SYNTIS BIO, INC. $25.0M of $26.5M · 94.3%
- Ronald Poropatich — Director, Pittsburgh, PA
- Eric Keller — Executive Officer / Director, Pittsburgh, PA
-
Houman Hemmati — Director, Pittsburgh, PA
1 other raise
- Trailhead Biosystems Inc. $40.6M of $40.6M · 100.0%
-
Craig Nemiroff — Director, Pittsburgh, PA
1 other raise
- Trailhead Biosystems Inc. $40.6M of $40.6M · 100.0%
-
Michael Kaufman — Director, Pittsburgh, PA
3 other raises
- Trailhead Biosystems Inc. $40.6M of $40.6M · 100.0%
- MAK One Fund LP $894.9M of —
- MAK Capital International Ltd $57.4M of —
- Karin Potoka — Executive Officer, Pittsburgh, PA
- Larry Brown — Executive Officer, Pittsburgh, PA
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.